Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 Receptor Agonists
This taste can be strong and unpleasant, lasting throughout the treatment period
A 2022 JAMA study on 338 adults who had overweight or obesity found that taking semaglutide and liraglutide, respectively, led to an average 15.8% and 6.4% loss in body weight over 68 weeks
[DOI] [PMC free article] [PubMed] [Google Scholar] 117.Kolterman O.G., Kim D.D., Shen L., et al
His hospital stay was brief, and he said his blood work had returned to normal within weeks of ceasing supplements
If you want a deeper explanation of how GLP-1 medications work, this guide to semaglutide side effects is a helpful related read